Position in FULC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$507,562
-$122,552 QoQ
Shares Held
66,175
+18.8% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 168 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 15.8579523989422.ToString("F0")%
Shared 0.ToString("F0")%
None 84.1420476010578.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. FULC ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in FULC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $507,562 | 66,175 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $630,114 | 55,713 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $638,222 | 69,372 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $572,760 | 83,250 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $256,299 | 88,993 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $416,452 | 88,607 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $311,332 | 87,208 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $566,878 | 91,432 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $15,642 | 1,657 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $11,184 | 1,657 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $7,357 | 1,657 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $15,810 | 4,791 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $215,194 | 75,507 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $434,834 | 59,730 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $410,381 | 50,727 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $232,882 | 47,527 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $806,819 | 34,115 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $560,896 | 31,707 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $851,913 | 30,199 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $235,538 | 22,475 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $145,541 | 12,355 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $138,939 | 11,865 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $84,176 | 10,615 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $232,740 | 12,725 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||